Bnc Korea KRX:256840KOSDAQ
한국비엔씨 · Korean news coverage and regulatory filings, organized.
Articles, 24h1
Articles, 7 days2
DART filings, 7 days0
Articles tracked2since Sep 11
In Q2 2026, Bnc Korea reported revenue of ₩24.6bn, down 0.1% year on year, and an operating loss of ₩366m. Bnc Korea (한국비엔씨) appeared in 2 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Sep 14 with 2 articles. The most common catalyst was contracts & orders (1). It was most often mentioned alongside iNtRON Biotechnology.
Bnc Korea quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩24.6bn | -0.1% | −₩366m | −₩1.7bn |
| Q1 2026 | ₩20.7bn | -18.4% | −₩1.5bn | −₩1.3bn |
| Q4 2025 derived | ₩23.6bn | -8.6% | −₩2.4bn | −₩3.0bn |
| Q3 2025 | ₩22.3bn | -5.2% | −₩1.4bn | −₩366m |
| Q2 2025 | ₩24.6bn | +8.4% | ₩1.6bn | ₩281m |
| Q1 2025 | ₩25.4bn | +47.6% | ₩3.8bn | ₩5.1bn |
| Q4 2024 derived | ₩25.8bn | +9.9% | ₩1.7bn | ₩8.6bn |
| Q3 2024 | ₩23.5bn | +15.3% | ₩3.4bn | ₩1.8bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.
Bnc Korea top stories 2 weeks, by number of outlets
- 1
- 2
